We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Study Shows Steep Rise in the Use of MRI Scans Before Breast Cancer Surgery

By HospiMedica International staff writers
Posted on 09 Oct 2015
The results of a new study have shown an eightfold rise in the use of Magnetic Resonance Imaging (MRI) scans before breast cancer surgery in the Canadian province of Ontario between 2003 and 2012.

Guidelines on the use of MRI scans before surgery are inconsistent, the study showed, and the increased use of MRI was characteristic of younger, wealthier patients, with a likelihood of additional health problems. More...
The study also found that the use of MRI scans in this context was linked to longer waiting times for surgery and additional testing, and a higher chance of mastectomy, including that of the healthy breast.

The researchers used a large number of healthcare databases in Ontario for the study, and evaluated more than 53,000 women that were diagnosed with breast cancer. The study was published online on September 24, 2015, in the journal JAMA Oncology. The researchers found that only 3% of patients had a preoperative MRI scan in 2003, while in 2012 nearly 24% received an MRI scan. A similar increase was also reported from the US.

MRI scanning is much more expensive than ultrasound, for example, and some of the scans may have been unnecessary. Guidelines for preoperative MRI are and confusing and inconsistent, according to a coauthor of the editorial that accompanied the study, Dr. Constance Lehman, director of breast imaging, Massachusetts General Hospital (Boston, MA, USA).

The study did not show the extent to which the MRI affected clinician’s decisions for further treatment since the medical records used did not indicate whether the results of the MRI scan were positive or negative.

Another coauthor of the study editorial, Dr. Habib Rahbar, University of Washington (Seattle, WA, USA), said, "It is important that we carefully consider how this powerful imaging tool can be used to provide more individualized and targeted therapies to women, rather than not use it altogether."

Related Links:

Massachusetts General Hospital
University of Washington, Seattle



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Portable Jaundice Management Device
Nymphaea
X-Ray Meter
Cobia SENSE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.